TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from MAIA Biotechnology, Inc. ( (MAIA) ) is now available.
On September 12, 2025, MAIA Biotechnology, Inc. updated its business presentation on its website, providing a summary of the company’s operations and strategic direction. This update is part of the company’s ongoing communication with stakeholders, although it does not commit to future updates, and includes forward-looking statements that investors should interpret with caution.
The most recent analyst rating on (MAIA) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on MAIA Biotechnology, Inc. stock, see the MAIA Stock Forecast page.
Spark’s Take on MAIA Stock
According to Spark, TipRanks’ AI Analyst, MAIA is a Neutral.
MAIA Biotechnology presents a mixed outlook. The company’s financial performance is weak due to its development-stage status and lack of revenue, contributing to a low financial performance score. However, recent positive trial results and technical indicators showing short-term upward momentum provide a more optimistic view. Valuation remains challenging due to negative earnings, but the potential for significant clinical advancements offers upside potential.
To see Spark’s full report on MAIA stock, click here.
More about MAIA Biotechnology, Inc.
Average Trading Volume: 477,915
Technical Sentiment Signal: Sell
Current Market Cap: $56.09M
See more data about MAIA stock on TipRanks’ Stock Analysis page.